Found: 7
Select item for more details and to access through your institution.
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune Responses.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 286, doi. 10.3390/vaccines11020286
- By:
- Publication type:
- Article
Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same Antigen.
- Published in:
- Vaccines, 2021, v. 9, n. 9, p. 959, doi. 10.3390/vaccines9090959
- By:
- Publication type:
- Article
Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.767370
- By:
- Publication type:
- Article
Dendritic Cells Exposed to MVA-Based HIV-1 Vaccine Induce Highly Functional HIV-1-Specific CD8+ T Cell Responses in HIV-1-Infected Individuals.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0019644
- By:
- Publication type:
- Article
The HIV-1 integrase-LEDGF allosteric inhibitor MUT-A: resistance profile, impairment of virus maturation and infectivity but without influence on RNA packaging or virus immunoreactivity.
- Published in:
- Retrovirology, 2017, v. 14, p. 1, doi. 10.1186/s12977-017-0373-2
- By:
- Publication type:
- Article
Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.
- Published in:
- Immunology, 2009, v. 128, n. 3, p. 393, doi. 10.1111/j.1365-2567.2009.03121.x
- By:
- Publication type:
- Article
Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV.
- Published in:
- Immunology & Cell Biology, 2009, v. 87, n. 8, p. 634, doi. 10.1038/icb.2009.53
- By:
- Publication type:
- Article